Untitled

HealthTrust presents…“Pharmacists at the Pump: Anticoagulation & Bleeding Management in Mechanical Circulatory Support”

Anticoagulation is necessary in mechanical circulatory support (MCS) to prevent device thrombosis caused by artificial surface contact and the prothrombotic effects of the device. Despite MCS advancements, bleeding remains a common, yet severe complication, that increases hospital morbidity and mortality. Management in the intensive care unit requires a balance between device thrombosis with bleeding. MCS encompasses technologies such as Impella devices, intra-aortic balloon pumps (IABP), left ventricular assist devices (LVADs), and extracorporeal membrane oxygenation (ECMO). Due to the risk of clotting with MCS, anticoagulation is used to mitigate thrombosis; however, this poses the risk of bleeding as well. Bleeding remains a common complication across these devices. This presentation aims to summarize the management of bleeding complications, specifically focusing on anticoagulant use, reversal agents and other therapies for prevention of bleeding within this patient population.

Learning Objectives for Pharmacists & Nurses | At the end of this session, participants should be able to:

1. Recall the incidence, pathophysiology and device-specific risk factors contributing to bleeding in patients with Mechanical Circulatory Support (MCS).
2. Identify anticoagulant strategies used in patients receiving MCS to include thrombosis prevention, bleeding risks, and monitoring strategies.
3. Recognize current and emerging evidence on reversal agents and novel pharmacologic therapies to treat and prevent bleeding in patients on MCS.

Learning Objectives for Pharmacists & Nurses | At the end of this session, participants should be able to:

1. Recognize strategies for effective education for patients receiving anticoagulant medications in the treatment of Mechanical Circulatory Support (MCS).
2. Identify patterns of nonadherence to anticoagulant medications.
3. Recall anticoagulation medications and potential side effects for patients with MCS.

Presenter:

Courtney Cianci, PharmD  | PGY-2 Critical Care Pharmacy Resident  |  Tristar Centennial Medical Center

Target Audience:  Pharmacists, Pharmacy Techs & Nurses

CE Credit: Approved for Nurses; pending for Pharmacists & Pharmacy Techs

This program is pending approval for CPEs by the Accreditation Council for Pharmacy Education (ACPE). Attendees of this program may earn 1.0 CPE Contact Hours. Belmont University College of Pharmacy & Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The Universal Activity Numbers for this activity are pending.

Pfiedler Education is a division of AORN, provider approved by the California Board of Registered Nursing, Provider Number CEP13019, for 1 contact hour. 1.0 contact hours approved for Nurses.

AORN is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. Level of instruction: Advanced. 1.0 Contact Hour

Belmont University CPHS Policy on Privacy & Confidentiality: 

• All registration information for CPE activities collected in the registration system and/or on paper (e.g., sign-in sheet) is kept confidential and used only for the purpose of awarding CPE credit.
• Archived recordings of CPE activities are edited so that only the presenter’s shared screen and image are visible. Comments entered into a chat box during the CPE activity will be excluded from the recording whenever possible.
• CPHS does not share with any third party (including ineligible companies) or its agents the names or contact information of CPE learners without the explicit consent of the individual learner. If a third-party requests that information be shared with CPHS CPE participants, CPHS will receive the requested information from the third party and share it with CPE participants via CPHS’s own communication methods.

Note about CE credit: If you plan to obtain credit for a live session, stay until the end of the presentation to receive the verification code you will need to obtain the continuing education credit. CE credit is individual. No group credit is available. Each person must register for a webinar and attend the webinar in its entirety in order to receive an email after the event with instructions on how to apply for continuing education credit. Attendees should not share the code or forward the email to others who did not actually attend the program. If they are not able to be verified on our webinar provider reports and registration list they will not receive credit. If you are joining only by phone, you will not be eligible for credit. You must also log in and join the visual portion of the webinar to be part of our CE provider-required reporting.